Travere Therapeutics Inc (TVTX)
Stock-Based Compensation
$60.66M
TTM · Period ending: · USD
TVTX Stock-Based Compensation
Latest reported$60.66Mperiod ending
Latest reported$60.66Mperiod ending
TVTX TTM Stock-Based Comp ($0.00 → $60.66M)
TTM stock-based compensation
High-resolution chart · PNG
TVTX stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 60,661,000 | |
| 49,522,000 | |
| 44,868,000 | |
| 42,618,000 | |
| 39,377,000 | |
| 38,647,000 | |
| 36,913,000 | |
| 35,843,000 | |
| 39,142,000 | |
| 40,533,000 | |
| 44,246,000 | |
| 45,630,000 | |
| 42,332,000 | |
| 43,659,000 | |
| 38,374,000 | |
| 37,422,000 | |
| 36,385,000 | |
| 31,044,000 | |
| 30,766,000 | |
| 28,542,000 | |
| 26,954,000 | |
| 25,612,000 | |
| 23,614,000 | |
| 21,759,000 | |
| 20,677,000 | |
| 20,744,000 | |
| 21,105,000 | |
| 21,268,000 | |
| 21,906,000 | |
| 21,386,000 | |
| 19,774,000 | |
| 20,696,000 | |
| 22,702,000 | |
| 24,440,000 | |
| 26,874,000 | |
| 28,360,000 | |
| 29,148,000 | |
| 29,402,000 | |
| 29,102,000 | |
| 29,186,000 | |
| 29,619,000 | |
| 27,119,723 | |
| 25,900,000 | |
| 19,939,355 | |
| 16,452,830 | |
| 16,467,378 | |
| 15,900,456 | |
| 14,671,649 | |
| 11,360,805 | |
| 6,410,050 | |
| 1,424,528 | |
| 9,857,800 | |
| 15,501,844 | |
| 15,444,328 | |
| 15,423,495 | |
| 7,027,675 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |